$613 Million is the total value of Bellevue Asset Management AG's 133 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 21.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Buy | Gilead Sciences, Inc. | $24,945,000 | -9.3% | 254,050 | +8.2% | 4.07% | +6.6% |
| CELG | Buy | Celgene Corporation | $24,853,000 | -6.1% | 229,760 | +0.5% | 4.05% | +10.4% |
| BIIB | Sell | Biogen Inc. | $20,943,000 | -28.7% | 71,770 | -1.4% | 3.42% | -16.2% |
| ABT | Abbott Laboratories | $18,622,000 | -18.1% | 463,000 | 0.0% | 3.04% | -3.7% | |
| REGN | Buy | Regeneron Pharmaceuticals, Inc. | $18,094,000 | -8.6% | 38,900 | +0.3% | 2.95% | +7.5% |
| MDT | Sell | Medtronic, Inc. | $18,074,000 | -12.9% | 270,000 | -3.6% | 2.95% | +2.4% |
| AMGN | Buy | Amgen Inc. | $16,598,000 | +11.6% | 120,000 | +23.9% | 2.71% | +31.2% |
| ILMN | Buy | Illumina, Inc. | $15,406,000 | -14.7% | 87,625 | +5.9% | 2.51% | +0.2% |
| UNH | Buy | UnitedHealth Group Incorporated | $13,921,000 | -0.8% | 120,000 | +4.3% | 2.27% | +16.6% |
| AGN | Buy | Allergan PLC | $13,631,000 | -9.1% | 50,150 | +1.5% | 2.22% | +6.8% |
| SYK | Stryker Corporation | $13,240,000 | -1.5% | 140,700 | 0.0% | 2.16% | +15.8% | |
| ESRX | Express Scripts Holding Company | $12,954,000 | -9.0% | 160,000 | 0.0% | 2.11% | +7.0% | |
| BDX | Buy | Becton, Dickinson and Company | $12,245,000 | -4.6% | 92,305 | +1.8% | 2.00% | +12.1% |
| ENDP | Sell | Endo International PLC | $10,946,000 | -26.9% | 158,000 | -16.0% | 1.78% | -14.1% |
| TEVA | Buy | Teva Pharmaceuticals, Inc.adr | $9,554,000 | -3.2% | 169,220 | +1.4% | 1.56% | +13.8% |
| MYL | Mylan Inc. | $9,059,000 | -40.7% | 225,000 | 0.0% | 1.48% | -30.3% | |
| ZBH | Zimmer Holdings, Inc. | $8,970,000 | -14.0% | 95,500 | 0.0% | 1.46% | +1.1% | |
| VRTX | Sell | Vertex Pharmaceuticals Incorporated | $8,592,000 | -21.4% | 82,500 | -6.8% | 1.40% | -7.6% |
| INCY | Buy | Incyte Corporation | $8,495,000 | +43.0% | 77,000 | +35.1% | 1.39% | +68.2% |
| RDY | Dr. Reddy's Laboratories Limitedadr | $8,308,000 | +15.5% | 130,000 | 0.0% | 1.36% | +35.8% | |
| LGND | Buy | Ligand Pharmaceuticals Incorporated | $8,199,000 | +6.6% | 95,730 | +25.6% | 1.34% | +25.3% |
| CI | Buy | Cigna Corporation | $7,831,000 | +7.4% | 58,000 | +28.9% | 1.28% | +26.2% |
| ALXN | Sell | Alexion Pharmaceuticals, Inc. | $7,726,000 | -17.4% | 49,400 | -4.5% | 1.26% | -2.9% |
| EARS | Auris Medical Holding AG | $7,724,000 | -27.9% | 2,169,625 | 0.0% | 1.26% | -15.3% | |
| STJ | Sell | St. Jude Medical, Inc. | $7,697,000 | -29.8% | 122,000 | -18.7% | 1.26% | -17.5% |
| MCK | McKesson Corporation | $7,586,000 | -17.7% | 41,000 | 0.0% | 1.24% | -3.3% | |
| JAZZ | Jazz Pharmaceuticals Public Limited Company | $7,437,000 | -24.6% | 56,000 | 0.0% | 1.21% | -11.3% | |
| CYH | Buy | Community Health Systems, Inc. | $6,943,000 | -25.6% | 162,340 | +9.5% | 1.13% | -12.6% |
| BMRN | BioMarin Pharmaceutical Inc. | $6,846,000 | -23.0% | 65,000 | 0.0% | 1.12% | -9.5% | |
| KITE | Sell | Kite Pharma, Inc. | $6,654,000 | -37.6% | 119,500 | -31.7% | 1.08% | -26.7% |
| BSX | Boston Scientific Corporation | $6,564,000 | -7.3% | 400,000 | 0.0% | 1.07% | +9.1% | |
| SHPG | Buy | Shire PLCsponsored adr | $6,340,000 | -5.6% | 30,890 | +11.1% | 1.03% | +11.1% |
| EW | Buy | Edwards Lifesciences Corporation | $6,327,000 | +30.3% | 44,500 | +30.5% | 1.03% | +53.1% |
| PRGO | Perrigo Company plc | $6,291,000 | -14.9% | 40,000 | 0.0% | 1.03% | 0.0% | |
| ISRG | Intuitive Surgical, Inc. | $6,227,000 | -5.1% | 13,550 | 0.0% | 1.02% | +11.5% | |
| CAH | Sell | Cardinal Health, Inc. | $6,146,000 | -40.3% | 80,000 | -35.0% | 1.00% | -29.8% |
| INSYQ | Buy | Insys Therapeutics, Inc. | $5,977,000 | +38.7% | 210,000 | +75.0% | 0.98% | +63.0% |
| AET | Buy | Aetna Inc. | $5,799,000 | +1.1% | 53,000 | +17.8% | 0.95% | +18.8% |
| ABC | AmerisourceBergen Corporation | $5,699,000 | -10.7% | 60,000 | 0.0% | 0.93% | +5.1% | |
| HUM | Buy | Humana, Inc. | $5,370,000 | +19.5% | 30,000 | +27.7% | 0.88% | +40.4% |
| ISIS | Buy | Isis Pharmaceuticals, Inc. | $5,335,000 | -24.0% | 132,000 | +8.2% | 0.87% | -10.7% |
| CVS | Buy | CVS Health Corporation | $5,306,000 | +1.2% | 55,000 | +10.0% | 0.86% | +18.8% |
| MNKKQ | Buy | Mallinckrodt public limited company | $5,115,000 | -13.1% | 80,000 | +60.0% | 0.83% | +2.1% |
| CLVS | Sell | Clovis Oncology, Inc. | $5,058,000 | +4.5% | 55,000 | -0.2% | 0.82% | +22.8% |
| XENT | Buy | Intersect Ent, Inc. | $4,675,000 | +25.6% | 199,777 | +53.7% | 0.76% | +47.9% |
| THC | Buy | Tenet Healthcare Corporation | $4,671,000 | -33.8% | 126,510 | +3.7% | 0.76% | -22.2% |
| JNJ | Johnson & Johnson | $4,668,000 | -4.2% | 50,000 | 0.0% | 0.76% | +12.6% | |
| CHRS | Sell | Coherus BioSciences, Inc | $4,609,000 | -36.2% | 230,000 | -8.0% | 0.75% | -25.0% |
| BCR | Sell | C.R. Bard, Inc. | $4,565,000 | -10.9% | 24,500 | -18.3% | 0.74% | +4.8% |
| SUPN | New | Supernus Pharmaceuticals, Inc. | $4,490,000 | – | 320,000 | +100.0% | 0.73% | – |
| HZNP | Buy | Horizon Pharma plc | $4,360,000 | -16.3% | 220,000 | +46.7% | 0.71% | -1.7% |
| ANTM | Anthem, Inc. | $4,200,000 | -14.7% | 30,000 | 0.0% | 0.68% | +0.3% | |
| AGIO | Buy | Agios Pharmaceuticals, Inc. | $3,812,000 | -16.3% | 54,000 | +31.7% | 0.62% | -1.6% |
| BMY | Bristol-Myers Squibb Company | $3,552,000 | -11.0% | 60,000 | 0.0% | 0.58% | +4.5% | |
| ALKS | Sell | Alkermes Public Limited Company | $3,462,000 | -50.9% | 59,000 | -46.1% | 0.56% | -42.2% |
| HALO | Buy | Halozyme Therapeutics, Inc. | $3,304,000 | +59.7% | 246,000 | +168.5% | 0.54% | +87.8% |
| CERN | Cerner Corporation | $3,298,000 | -13.2% | 55,000 | 0.0% | 0.54% | +2.1% | |
| AKRXQ | Sell | Akorn, Inc. | $3,206,000 | -42.7% | 112,470 | -12.2% | 0.52% | -32.6% |
| ZFGN | New | Zafgen Inc. | $3,195,000 | – | 100,000 | +100.0% | 0.52% | – |
| HOLX | Hologic, Inc. | $3,170,000 | +2.8% | 81,000 | 0.0% | 0.52% | +20.8% | |
| HCA | HCA Holdings, Inc. | $3,094,000 | -14.7% | 40,000 | 0.0% | 0.50% | +0.2% | |
| MRK | Sell | Merck & Co., Inc. | $2,963,000 | -25.6% | 60,000 | -14.3% | 0.48% | -12.7% |
| XRAY | DENTSPLY International Inc. | $2,953,000 | -1.9% | 58,400 | 0.0% | 0.48% | +15.3% | |
| LLY | Buy | Lilly Eli & Co. | $2,929,000 | +75.4% | 35,000 | +75.0% | 0.48% | +106.0% |
| ACHN | Buy | Achillion Pharmaceuticals, Inc. | $2,902,000 | -12.9% | 420,000 | +11.7% | 0.47% | +2.4% |
| MASI | Masimo Corporation | $2,892,000 | -0.5% | 75,000 | 0.0% | 0.47% | +17.1% | |
| ARIA | ARIAD Pharmaceuticals, Inc. | $2,891,000 | -29.4% | 495,000 | 0.0% | 0.47% | -16.9% | |
| SRCL | Buy | Stericycle, Inc. | $2,786,000 | +38.7% | 20,000 | +33.3% | 0.45% | +62.7% |
| COO | Cooper Companies Inc. | $2,754,000 | -16.3% | 18,500 | 0.0% | 0.45% | -1.8% | |
| VAR | Sell | Varian Medical Systems, Inc. | $2,730,000 | -22.9% | 37,000 | -11.9% | 0.44% | -9.4% |
| PFE | Sell | Pfizer Inc. | $2,670,000 | -20.4% | 85,000 | -15.0% | 0.44% | -6.5% |
| NKTR | Buy | Nektar Therapeutics | $2,650,000 | +5.9% | 240,000 | +20.0% | 0.43% | +24.5% |
| NVDQ | Buy | Novadaq Technologies Inc. | $2,608,000 | +185.0% | 250,000 | +230.7% | 0.42% | +234.6% |
| NBIX | Neurocrine Biosciences, Inc. | $2,586,000 | -16.7% | 65,000 | 0.0% | 0.42% | -2.1% | |
| ALNY | Sell | Alnylam Pharmaceuticals Inc. | $2,572,000 | -60.3% | 32,000 | -40.7% | 0.42% | -53.2% |
| TMO | Buy | Thermo Fisher Scientific Inc. | $2,446,000 | +45.0% | 20,000 | +53.8% | 0.40% | +70.5% |
| HTWR | Buy | Heartware International, Inc. | $2,354,000 | +47.2% | 45,000 | +104.5% | 0.38% | +73.0% |
| TFX | Sell | Teleflex Incorporated | $2,305,000 | -43.3% | 18,557 | -38.1% | 0.38% | -33.3% |
| NVAX | Sell | Novavax, Inc. | $2,298,000 | -60.3% | 325,000 | -37.5% | 0.38% | -53.4% |
| MDVN | Sell | Medivation, Inc. | $2,236,000 | -68.1% | 52,600 | -14.2% | 0.36% | -62.4% |
| HCSG | Healthcare Services Group Inc. | $2,191,000 | +2.0% | 65,000 | 0.0% | 0.36% | +19.8% | |
| NUVA | Nuvasive, Inc. | $2,170,000 | +1.8% | 45,000 | 0.0% | 0.35% | +19.6% | |
| QGEN | Buy | Qiagen NV | $2,064,000 | +38.8% | 80,000 | +33.3% | 0.34% | +63.6% |
| UBIO | New | Ultra NASDAQ Biotechnologyultrapro nasbio | $2,039,000 | – | 35,000 | +100.0% | 0.33% | – |
| ACAD | Sell | Acadia Pharmaceuticals, Inc. | $1,951,000 | -53.9% | 59,000 | -41.6% | 0.32% | -45.8% |
| SGEN | Buy | Seattle Genetics, Inc. | $1,851,000 | -4.4% | 48,000 | +20.0% | 0.30% | +12.3% |
| GMED | Globus Medical, Inc.cl a | $1,812,000 | -19.5% | 87,700 | 0.0% | 0.30% | -5.1% | |
| MGNX | Buy | Macrogenics, Inc. | $1,778,000 | -42.2% | 83,000 | +2.5% | 0.29% | -32.1% |
| BLUE | Buy | Bluebird Bio, Inc. | $1,754,000 | -47.9% | 20,500 | +2.5% | 0.29% | -38.8% |
| WCG | WellCare Health Plans, Inc. | $1,724,000 | +1.6% | 20,000 | 0.0% | 0.28% | +19.6% | |
| CLDX | Buy | Celldex Therapeutics, Inc. | $1,686,000 | -9.6% | 160,000 | +116.2% | 0.28% | +6.2% |
| BAX | New | Baxter International Inc. | $1,643,000 | – | 50,000 | +100.0% | 0.27% | – |
| INO | Buy | Inovio Pharmaceuticals, Inc. | $1,532,000 | -6.1% | 265,000 | +32.5% | 0.25% | +10.6% |
| ABBV | Abbvie Inc. | $1,469,000 | -19.0% | 27,000 | 0.0% | 0.24% | -4.8% | |
| DVA | Sell | Davita Healthcare Partners, Inc. | $1,447,000 | -30.0% | 20,000 | -23.1% | 0.24% | -17.8% |
| ICPT | Buy | Intercept Pharmaceuticals, Inc. | $1,443,000 | -20.3% | 8,700 | +16.0% | 0.24% | -6.4% |
| ALDR | New | Alder Biopharmaceuticals Inc. | $1,409,000 | – | 43,000 | +100.0% | 0.23% | – |
| JUNO | Sell | Juno Therapeutics, Inc. | $1,343,000 | -47.5% | 33,000 | -31.2% | 0.22% | -38.3% |
| ANGO | AngioDynamics, Inc. | $1,319,000 | -19.6% | 100,000 | 0.0% | 0.22% | -5.7% | |
| MYGN | Sell | Myriad Genetics, Inc. | $1,237,000 | -4.3% | 33,000 | -13.2% | 0.20% | +12.8% |
| UTHR | United Therapeutics Corporation | $1,221,000 | -24.5% | 9,300 | 0.0% | 0.20% | -11.6% | |
| KANG | Buy | iKang Healthcare Group, Inc.sponsored adr | $1,110,000 | +14.8% | 75,000 | +50.0% | 0.18% | +35.1% |
| INFI | Sell | Infinity Pharmaceuticals, Inc. | $1,099,000 | -38.8% | 130,000 | -20.7% | 0.18% | -28.1% |
| CNC | Buy | Centene Corporation | $1,085,000 | -10.0% | 20,000 | +33.3% | 0.18% | +6.0% |
| LH | Laboratory Corporation of America Holdings | $1,085,000 | -10.5% | 10,000 | 0.0% | 0.18% | +5.4% | |
| MNKD | MannKind Corporation | $963,000 | -43.6% | 300,000 | 0.0% | 0.16% | -33.8% | |
| ESPR | Buy | Esperion Therapeutics Inc. | $944,000 | -57.2% | 40,000 | +48.1% | 0.15% | -49.7% |
| EXEL | Buy | Exelixis, Inc. | $842,000 | +123.9% | 150,000 | +50.0% | 0.14% | +163.5% |
| TMH | New | Team Health Holdings Inc. | $810,000 | – | 15,000 | +100.0% | 0.13% | – |
| RMD | ResMed Inc. | $764,000 | -9.7% | 15,000 | 0.0% | 0.12% | +6.8% | |
| IBB | New | Ishares TRnasdaq biotec etf | $758,000 | – | 2,500 | +100.0% | 0.12% | – |
| ABUS | New | Arbutus Biopharm Corporation | $761,000 | – | 125,000 | +100.0% | 0.12% | – |
| ECYT | Endocyte, Inc. | $724,000 | -11.7% | 158,000 | 0.0% | 0.12% | +3.5% | |
| PRTA | Buy | Prothena Corporation plc | $680,000 | -0.7% | 15,000 | +15.4% | 0.11% | +16.8% |
| AFFX | Affymetrix, Inc. | $683,000 | -21.9% | 80,000 | 0.0% | 0.11% | -8.3% | |
| IPXL | Sell | Impax Laboratories, Inc. | $634,000 | -57.6% | 18,000 | -44.8% | 0.10% | -50.5% |
| ELGX | Endologix, Inc. | $613,000 | -20.1% | 50,000 | 0.0% | 0.10% | -5.7% | |
| JNP | Sell | Juniper Pharmaceuticals Inc. | $589,000 | -41.5% | 50,000 | -54.5% | 0.10% | -31.4% |
| PODD | Sell | Insulet Corporation | $583,000 | -64.2% | 22,500 | -57.1% | 0.10% | -58.0% |
| CSII | Buy | Cadiovascular Systems Inc. | $475,000 | -10.2% | 30,000 | +50.0% | 0.08% | +5.5% |
| PEN | New | Penumbra Inc. | $401,000 | – | 10,000 | +100.0% | 0.06% | – |
| IMGN | New | Immunomedics, Inc. | $288,000 | – | 30,000 | +100.0% | 0.05% | – |
| DYAX | Sell | Dyax Corporation | $286,000 | -64.0% | 15,000 | -50.0% | 0.05% | -57.3% |
| THRX | Theravance, Inc. | $251,000 | -60.3% | 35,000 | 0.0% | 0.04% | -53.4% | |
| New | Rewalk Robotics Ltd. | $229,000 | – | 30,000 | +100.0% | 0.04% | – | |
| T107PS | Wright Medical Group Inc. | $210,000 | -20.2% | 10,000 | 0.0% | 0.03% | -5.6% | |
| XOMA | Sell | XOMA Corporation | $169,000 | -85.2% | 225,000 | -23.7% | 0.03% | -82.4% |
| TTPH | Buy | Tetraphase Pharmaceuticals, Inc. | $164,000 | -71.2% | 22,000 | +83.3% | 0.03% | -65.8% |
| TBPH | Theravance Biopharma, Inc. | $126,000 | -15.4% | 11,428 | 0.0% | 0.02% | 0.0% | |
| GERN | Geron Corporation | $124,000 | -35.8% | 45,000 | 0.0% | 0.02% | -25.9% | |
| CLDN | Sell | Celladon Corporation | $53,000 | -44.2% | 50,000 | -33.3% | 0.01% | -30.8% |
| AST | Asterias Biotherapeutics, Inc. | $7,000 | -22.2% | 1,875 | 0.0% | 0.00% | 0.0% | |
| BTXWS | Exit | BioTime, Inc.w exp 10/01/2018 | $0 | – | -2,294 | -100.0% | 0.00% | – |
| BTX | New | Biotime Inc. | $2,000 | – | 2,294 | +100.0% | 0.00% | – |
| CERS | Exit | Cerus Corporation | $0 | – | -46,520 | -100.0% | -0.03% | – |
| PRXL | Exit | Parexel International Corporation | $0 | – | -5,000 | -100.0% | -0.04% | – |
| PBYI | Exit | Puma Biotechnology, Inc. | $0 | – | -3,000 | -100.0% | -0.05% | – |
| GI | Exit | EndoChoice Holdings, Inc. | $0 | – | -22,056 | -100.0% | -0.05% | – |
| RLYP | Exit | Relypsa, Inc. | $0 | – | -15,000 | -100.0% | -0.07% | – |
| ENTL | Exit | Entellus Medical, Inc. | $0 | – | -20,000 | -100.0% | -0.07% | – |
| MDSO | Exit | Medidata Solutions, Inc. | $0 | – | -10,000 | -100.0% | -0.08% | – |
| TNDM | Exit | Tandem Diabetes Care, Inc. | $0 | – | -50,000 | -100.0% | -0.08% | – |
| SGMO | Exit | Sangamo Biosciences, Inc. | $0 | – | -50,000 | -100.0% | -0.08% | – |
| TSRO | Exit | Tesaro, Inc. | $0 | – | -10,300 | -100.0% | -0.08% | – |
| ABMD | Exit | Abiomed, Inc. | $0 | – | -10,000 | -100.0% | -0.09% | – |
| ATHN | Exit | Athenahealth, Inc. | $0 | – | -8,000 | -100.0% | -0.13% | – |
| IMMU | Exit | Immunomedics, Inc. | $0 | – | -300,000 | -100.0% | -0.17% | – |
| TKMR | Exit | Tekmira Pharmaceuticals Corp. | $0 | – | -125,000 | -100.0% | -0.21% | – |
| DHR | Exit | Danaher Corporation | $0 | – | -19,000 | -100.0% | -0.23% | – |
| THOR | Exit | Thoratec Corporation | $0 | – | -55,000 | -100.0% | -0.34% | – |
| RCPT | Exit | Receptos, Inc. | $0 | – | -34,000 | -100.0% | -0.90% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-11-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Biogen Inc. | 4 | Q4 2015 | 4.2% |
| Celgene Corporation | 4 | Q4 2015 | 4.1% |
| Gilead Sciences, Inc. | 4 | Q4 2015 | 4.1% |
| Medtronic, Inc. | 4 | Q4 2015 | 3.7% |
| Abbott Laboratories | 4 | Q4 2015 | 3.3% |
| Regeneron Pharmaceuticals, Inc. | 4 | Q4 2015 | 3.0% |
| Amgen Inc. | 4 | Q4 2015 | 3.0% |
| Illumina, Inc. | 4 | Q4 2015 | 2.7% |
| UnitedHealth Group Incorporated | 4 | Q4 2015 | 2.3% |
| Stryker Corporation | 4 | Q4 2015 | 2.2% |
View Bellevue Asset Management AG's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Auris Medical Holding AG | February 14, 2018 | 2,169,625 | 4.5% |
View Bellevue Asset Management AG's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-NT | 2024-02-14 |
| 13F-NT | 2023-11-14 |
| 13F-NT | 2023-08-14 |
| 13F-NT | 2023-05-15 |
| 13F-NT | 2023-02-14 |
| 13F-NT | 2022-11-14 |
| 13F-NT | 2022-08-11 |
| 13F-NT | 2022-05-13 |
| 13F-NT | 2022-02-10 |
| 13F-NT | 2021-11-12 |
View Bellevue Asset Management AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.